Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer.
Journal: Molecular cancer therapeutics
Published: April 28, 2021
Correction to: Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients.
Journal: Cancer immunology, immunotherapy : CII
Published: March 29, 2020
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study.
Journal: Gynecologic oncology
Published: November 11, 2019
Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma.
Journal: American journal of clinical oncology
Published: September 13, 2019
Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients.
Journal: Cancer immunology, immunotherapy : CII
Published: May 06, 2019
Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors.
Journal: Cancer immunology, immunotherapy : CII
Published: December 02, 2016
Antibody-based immunotherapy of solid cancers: progress and possibilities.
Journal: Immunotherapy
Published: August 29, 2015
Discordant biological and toxicological species responses to TLR3 activation.
Journal: The American journal of pathology
Published: August 19, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026